The Scientist - Home

A study makes policy recommendations to optimize citations, but critics say it fails to acknowledge that citations are a biased and narrow measure of scientific success.

Responses collected from around 25,000 academics reveal that 20 percent couldn’t do their work at all in the spring, but most had found ways to keep their research going.

Academics will soon be able to make articles freely available in Nature-branded journals for €9,500—with a discounted option available under a pilot program that provides review, but no guarantee of acceptance.

Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.

Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.

The variant causes a buildup of BACE1 protein in axons in cultured neurons and mice. Researchers say it might be time to rethink failed trials that inhibit BACE1 to treat the neurodegenerative disease.

A study explains how Zika was present among mosquitoes in Africa for decades without causing the harm to human health seen outside the continent in recent years.

Rather than introducing small chunks of DNA as other viruses do, some giant viruses can contribute more than 1 million base pairs to a host’s genome, broadening the ways in which viruses may shape eukaryote evolution.

One of the first analyses of its kind finds a smaller proportion of men in same-sex couples earn STEM degrees than do men in heterosexual couples. It’s a different story for women.

This month, voters in the state approved the predators’ reintroduction, but the species’ recent delisting as an endangered species at the federal level binds up available funding.

A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.

An abundance of immunoglobulin antibodies, and a paucity of viral RNA, in breastmilk offer evidence that women can safely continue breastfeeding during the pandemic.